Predicting the tolerability of inhalation therapy as a stage of a personalized approach in the treatment of children with cystic fibrosis
Background. Considering the features of basic therapy for chronic inflammatory bronchopulmonary process in cystic fibrosis (CF), which includes almost daily inhalation of pharmacological drugs (mucolytics, hypertonic saline (HS), antibiotics), evaluation of their tolerability is relevant in practice...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | 図書 |
| 出版事項: |
Zaslavsky O.Yu.,
2023-04-01T00:00:00Z.
|
| 主題: | |
| オンライン･アクセス: | Connect to this object online. |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
インターネット
Connect to this object online.3rd Floor Main Library
| 請求記号: |
A1234.567 |
|---|---|
| 所蔵 1 | 利用可 |